The Dxcover Platform for Detection of Cancer

We have successfully completed two ground breaking studies on earlier diagnosis of brain cancer, and we are currently developing our platform for the detection of commonly occurring cancers.

How does it work?

The Dxcover platform combines novel hardware with artificial intelligence algorithms to analyse a patient's blood and detect the presence or absence of disease.

SYMPTOMATIC
PATIENTS
BLOOD SERUM
INFRARED SPECTROSCOPY
DIAGNOSTIC ALGORITHM
DISEASE PREDICTION
Chroma-Background.jpg
Sample_slides.jpg
Dxcover® Sample Slide

Sample is dropped onto a disposable Dxcover Slide and dried for analysis.

_indexing.jpg
Dxcover® Indexing Unit

The indexer unit enables rapid infrared analysis of the sample.

Technology_MG_2840.jpg
Dxcover® Platform

The Dxcover Platform detects the presence or absence of disease in minutes.

A drop of blood serum is dried on a Dxcover® Slide and analysed with infrared light. Data is captured from all the vital components, including the body’s response to disease. The Artificial Intelligence algorithm provides a result in minutes.

dropdrydetect_white.png
Chroma-Background_07.jpg

2021

Early diagnosis of brain tumours using a novel spectroscopic liquid biopsy

Paul M Brennan, Holly J Butler, Loren Christie, Mark G Hegarty...

2020

Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection

A Sala, DJ Anderson, PM Brennan, HJ Butler, JM Cameron, ...
Cancer letters 477, 122-130

2019

Development of high-throughput ATR-FTIR technology for rapid triage of brain cancer

HJ Butler, PM Brennan, JM Cameron, D Finlayson, MG Hegarty, ...
Nature communications 10 (1), 1-9

Key
Publications

1dxcover_v2_reduced.jpg